Process maps in clinical trial quality assurance

被引:2
|
作者
Rosen, Daniel H. [1 ]
Johnson, Sandra [2 ]
Kebaabetswe, Poloko [2 ]
Thigpen, Michael [2 ]
Smith, Dawn K. [2 ]
机构
[1] CDC, Global AIDS Program, Atlanta, GA 30333 USA
[2] BOTUSA, CDC, Gaborone, Botswana
关键词
PROCESS IMPROVEMENT;
D O I
10.1177/1740774509338429
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background A process map is a diagram showing the sequential steps and decisions used to accomplish a procedure from start to finish. Process maps are a standard tool in continuous improvement efforts. They have not been used routinely in clinical trials although they are well suited to display trial processes. Purpose We present the use of process maps as a tool to visualize and to monitor the correctness of trial work flows. We show that process maps can be used to assure that trial processes are conducted according to the SOP. Methods We describe how a process map is made. We then derive process maps from two sources: the SOP and trial procedures as currently implemented. We compare these maps to each other, using the SOP maps as the gold standard, to check that work is done according to the written procedures. Results Eight process maps were produced from each source. 172 differences were found between the SOP maps and the walkthrough maps. Differences included the addition of extra steps, order errors, step mistakes, and ambiguities. Limitations These process maps focused only on clinic procedures, so interactions with other trial components were not considered. The maps were made after the trial started, which may have biased their content and use. Conclusion Process maps are a simple tool to check if clinical trial processes are operating as designed and offer an effective means to identify and correct such divergences. Further research should focus on using process maps in the design phase of trials, analyzing the cost to benefit ratio for process maps, and linking the analysis of the process map to monitor queries to quantify the improvement gained from using this technique. Clinical Trials 2009;6:373-377.http://ctj.sagepub.com
引用
收藏
页码:373 / 377
页数:5
相关论文
共 50 条
  • [31] Quality assurance in clinical trials
    Feigenbaum, SL
    SEMINARS IN REPRODUCTIVE ENDOCRINOLOGY, 1996, 14 (02): : 93 - 100
  • [32] QUALITY ASSURANCE AND THE CLINICAL LABORATORY
    WONG, ET
    NELSON, JM
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 259 (17): : 2584 - 2585
  • [33] Quality assurance in clinical oncology
    Diehl, V
    deMulder, P
    Therasse, P
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 102 - 102
  • [34] QUALITY ASSURANCE AND CLINICAL MICROBIOLOGY
    MARTIN, RJ
    MEDICAL LABORATORY SCIENCES, 1983, 40 (03): : 269 - 274
  • [35] QUALITY ASSURANCE IN CLINICAL RESEARCH
    PETER, K
    DIETERICH, HJ
    ANASTHESIOLOGIE & INTENSIVMEDIZIN, 1992, 33 (11): : 337 - 339
  • [36] Quality assurance for clinical trials
    Ibbott, Geoffrey S.
    Haworth, Annette
    Followill, David S.
    FRONTIERS IN ONCOLOGY, 2013, 3
  • [37] Quality assurance in clinical perfusion
    Svenmarker, S
    Häggmark, S
    Jansson, E
    Lindholm, R
    Appelblad, M
    Åberg, T
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1998, 14 (04) : 409 - 414
  • [38] GEOECOLOGICAL MAPS QUALITY ASSURANCE AT THE STAGES OF CREATION AND USE
    Liashenko, D.
    Tsiupa, I.
    Babiy, V.
    Chekhniy, V.
    VISNYK OF TARAS SHEVCHENKO NATIONAL UNIVERSITY OF KYIV-GEOLOGY, 2022, (04): : 85 - 94
  • [39] Radiotherapy quality assurance in the TREC trial
    Abbott, N.
    Jones, G. W.
    Parsons, P.
    Lewis, D. G.
    Spezi, E.
    Kaur, M.
    Magill, L.
    Gray, R.
    Bach, S. P.
    Sebag-Montefiore, D.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S910 - S910
  • [40] Audit of the Informed Consent Process as a Part of a Clinical Research Quality Assurance Program
    Lad, Pramod M.
    Dahl, Rebecca
    SCIENCE AND ENGINEERING ETHICS, 2014, 20 (02) : 469 - 479